2010
DOI: 10.1002/cyto.b.20515
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of platelet counts by CellDyn Sapphire (Abbot Diagnostics), LH750 (Beckman Coulter), ReaPanThrombo immunoplatelet method (ReaMetrix), and the international flow reference method, in thrombocytopenic blood samples

Abstract: Background: We compared the international flow reference method (IRM) platelet counts with those obtained from CellDyn Sapphire (impedance and optical counts), LH750 (impedance counts), and the flowcytometry based ReaPanThrombo Immunoplatelet method (ReaMetrix). We further evaluated the degree of agreement of above methods with the IRM at the transfusion thresholds of 10 3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…Thus, many instrument manufacturers have applied a variety of measures to solve this problem. Advia 120, Cell-Dyn 4000, Mindray BC-6800 and Abbot Diagnostics are platelet counters using the optical counting method that can differentiate blood components according to the type and strength of light signals [46]. Another analyzer, the Sysmex XN-3000, is designed to use the method of fluorescent nucleic acid staining to count platelets [7].…”
Section: Introductionmentioning
confidence: 99%
“…Thus, many instrument manufacturers have applied a variety of measures to solve this problem. Advia 120, Cell-Dyn 4000, Mindray BC-6800 and Abbot Diagnostics are platelet counters using the optical counting method that can differentiate blood components according to the type and strength of light signals [46]. Another analyzer, the Sysmex XN-3000, is designed to use the method of fluorescent nucleic acid staining to count platelets [7].…”
Section: Introductionmentioning
confidence: 99%
“…Even when the value of prophylactic therapy is accepted the platelet count threshold at which this is justifi ed is still very much a matter of debate and it is certainly true that not all patients with severe thrombocytopenia should be considered autothomatic candidates for prophylactic therapy [37,38,39].…”
Section: Discussionmentioning
confidence: 99%